Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Stem Cell Transplantation (HCT) for Severe Combined Immunodeficiency (SCID) Patients: a Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT

Severe Combined Immunodeficiency (SCID) is one of the most common indications for pediatric hematopoietic cell transplantation (HCT) in patients with primary immunodeficiency (PID). Historically, SCID was diagnosed in infants who presented with opportunistic infections within the first year of life....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Biol Blood Marrow Transplant
Main Authors: Heimall, J, Puck, J, Buckley, R H, Fleisher, T A, Gennery, A R, Neven, B, Slatter, M, Haddad, E, Notarangelo, L, Baker, KS, Dietz, A C, Duncan, C, Pulsipher, M A, Cowan, MJ
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5659271/
https://ncbi.nlm.nih.gov/pubmed/28068510
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2016.12.619
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados